Organization | Marshfield Clinic Research Foundation

Marshfield Clinic Research Foundation Report issue

Foundation Phase 4

Founded: Marshfield WI United States (1959)

Organization Overview

First Clinical Trial

2007

NCT00484640

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Alternative names

Marshfield Clinic/MCRF | Marshfield Clinic Research Foundation | Marshfield Clinic Research Foundation - Center for Clinical Epidemiology & Population Health

Active Ingredients

Drugs in Phase 4 Trials (4)

azficel-T (Laviv) (1 trial)

flulaval (1 trial)

inactivated influenza vaccine (2 trials)

influenza vaccine, recombinant hemagglutinin (1 trial)

Drugs in Other Trials (4)

lidocaine (xylocaine) (1 trial)

oseltamivir (tamiflu) (1 trial)

urea (1 trial)

warfarin (coumadin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Communicable Diseases (Phase 4)

Herpesviridae Infections (Phase 4)

Infections (Phase 4)

Influenza, Human (Phase 4)

Virus Diseases (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial APIs: 8